✨ Medicines Consent Notices




568 NEW ZEALAND GAZETTE, No. 25 4 MARCH 2010

Product: Sebivo
Active Ingredient: Telbivudine 20mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma SAS, Huningue, France

Product: Voltaren Rapid 12.5 Soft Caps
Active Ingredient: Diclofenac potassium 12.5mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: R P Scherer GmbH & Co KG, Baden, Germany

Product: Voltaren Rapid 25 Soft Caps
Active Ingredient: Diclofenac potassium 25mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: R P Scherer GmbH & Co KG, Baden, Germany

Dated this 24th day of February 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1665

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Catapres
Active Ingredient: Clonidine hydrochloride 150ΞΌg
Dosage Form: Tablet
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturers: Boehringer Ingelheim France, Cedex, France
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

Dated this 26th day of February 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1664

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Carvedilol
Active Ingredient: Carvedilol 3.125mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra State, India

Product: Carvedilol
Active Ingredient: Carvedilol 6.25mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra State, India

Product: Carvedilol
Active Ingredient: Carvedilol 12.5mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra State, India

Product: Carvedilol
Active Ingredient: Carvedilol 25mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra State, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 25





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
24 February 2010
Medicines Act, Consent, Sebivo, Voltaren Rapid 12.5, Voltaren Rapid 25, Novartis, Diclofenac potassium
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
26 February 2010
Medicines Act, Consent, Catapres, Clonidine hydrochloride, Boehringer Ingelheim
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
26 February 2010
Medicines Act, Consent, Carvedilol, REX Medical Limited, Cipla Limited
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health